BriaCell Therapeutics (BCTX) Competitors $0.79 -0.02 (-2.46%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends BCTX vs. KRON, IMRX, BRNS, SPRO, EVOK, THTX, ATNM, CALC, BGM, and MNPRShould you be buying BriaCell Therapeutics stock or one of its competitors? The main competitors of BriaCell Therapeutics include Kronos Bio (KRON), Immuneering (IMRX), Barinthus Biotherapeutics (BRNS), Spero Therapeutics (SPRO), Evoke Pharma (EVOK), Theratechnologies (THTX), Actinium Pharmaceuticals (ATNM), CalciMedica (CALC), Qilian International Holding Group (BGM), and Monopar Therapeutics (MNPR). These companies are all part of the "pharmaceutical preparations" industry. BriaCell Therapeutics vs. Kronos Bio Immuneering Barinthus Biotherapeutics Spero Therapeutics Evoke Pharma Theratechnologies Actinium Pharmaceuticals CalciMedica Qilian International Holding Group Monopar Therapeutics BriaCell Therapeutics (NASDAQ:BCTX) and Kronos Bio (NASDAQ:KRON) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, community ranking, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends. Does the media favor BCTX or KRON? In the previous week, Kronos Bio had 2 more articles in the media than BriaCell Therapeutics. MarketBeat recorded 3 mentions for Kronos Bio and 1 mentions for BriaCell Therapeutics. BriaCell Therapeutics' average media sentiment score of 3.00 beat Kronos Bio's score of 0.66 indicating that BriaCell Therapeutics is being referred to more favorably in the media. Company Overall Sentiment BriaCell Therapeutics Very Positive Kronos Bio Positive Does the MarketBeat Community favor BCTX or KRON? Kronos Bio received 12 more outperform votes than BriaCell Therapeutics when rated by MarketBeat users. However, 100.00% of users gave BriaCell Therapeutics an outperform vote while only 70.00% of users gave Kronos Bio an outperform vote. CompanyUnderperformOutperformBriaCell TherapeuticsOutperform Votes9100.00% Underperform VotesNo VotesKronos BioOutperform Votes2170.00% Underperform Votes930.00% Do insiders and institutionals have more ownership in BCTX or KRON? 15.4% of BriaCell Therapeutics shares are held by institutional investors. Comparatively, 64.1% of Kronos Bio shares are held by institutional investors. 21.8% of BriaCell Therapeutics shares are held by insiders. Comparatively, 24.4% of Kronos Bio shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more risk & volatility, BCTX or KRON? BriaCell Therapeutics has a beta of 1.34, suggesting that its share price is 34% more volatile than the S&P 500. Comparatively, Kronos Bio has a beta of 1.87, suggesting that its share price is 87% more volatile than the S&P 500. Which has higher earnings and valuation, BCTX or KRON? BriaCell Therapeutics has higher earnings, but lower revenue than Kronos Bio. BriaCell Therapeutics is trading at a lower price-to-earnings ratio than Kronos Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBriaCell TherapeuticsN/AN/A-$20.30M-$1.17-0.68Kronos Bio$6.29M9.49-$112.67M-$1.74-0.57 Is BCTX or KRON more profitable? BriaCell Therapeutics has a net margin of 0.00% compared to Kronos Bio's net margin of -1,222.83%. BriaCell Therapeutics' return on equity of 0.00% beat Kronos Bio's return on equity.Company Net Margins Return on Equity Return on Assets BriaCell TherapeuticsN/A N/A -44.65% Kronos Bio -1,222.83%-68.82%-51.52% Do analysts rate BCTX or KRON? BriaCell Therapeutics currently has a consensus target price of $15.00, indicating a potential upside of 1,787.98%. Kronos Bio has a consensus target price of $4.13, indicating a potential upside of 316.67%. Given BriaCell Therapeutics' higher possible upside, equities analysts clearly believe BriaCell Therapeutics is more favorable than Kronos Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BriaCell Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Kronos Bio 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryBriaCell Therapeutics and Kronos Bio tied by winning 8 of the 16 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BCTX vs. The Competition Export to ExcelMetricBriaCell TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$28.48M$7.42B$5.50B$8.53BDividend YieldN/A7.96%5.13%4.14%P/E Ratio-0.6810.05116.1015.23Price / SalesN/A400.761,496.2597.74Price / CashN/A47.3939.7434.10Price / Book-3.315.594.775.07Net Income-$20.30M$153.56M$119.06M$225.46M7 Day Performance-8.36%0.13%0.80%0.37%1 Month Performance-21.34%15.23%5.65%3.57%1 Year Performance-79.78%41.14%36.75%29.43% BriaCell Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BCTXBriaCell Therapeutics2.9557 of 5 stars$0.79-2.5%$15.00+1,788.0%-79.8%$28.48MN/A-0.6816Earnings ReportPositive NewsGap UpKRONKronos Bio3.5565 of 5 stars$0.98flat$4.13+320.5%+17.4%$59.15M$8.41M-0.56100Short Interest ↓News CoverageIMRXImmuneering3.7768 of 5 stars$1.95-1.5%$12.60+546.2%-71.1%$57.82M$320,000.00-1.0260Short Interest ↓News CoveragePositive NewsBRNSBarinthus Biotherapeutics3.4816 of 5 stars$1.45+2.8%$5.83+302.3%N/A$57.16M$800,000.00-0.88107Short Interest ↓News CoverageSPROSpero Therapeutics4.6815 of 5 stars$1.05-19.8%$7.00+566.7%+3.5%$56.69M$105.43M3.1846News CoverageHigh Trading VolumeEVOKEvoke Pharma0.8929 of 5 stars$6.52+3.5%N/A-59.7%$56.05M$7.53M-0.404THTXTheratechnologiesN/A$1.20-2.4%N/A+37.1%$55.18M$84.32M-12.00140ATNMActinium Pharmaceuticals1.45 of 5 stars$1.84-1.9%$11.40+518.1%N/A$54.93M$81,000.00-1.2249Gap UpCALCCalciMedica3.4605 of 5 stars$5.09+29.5%$20.67+306.0%+63.3%$54.72MN/A-3.6430Insider BuyingShort Interest ↓News CoverageBGMQilian International Holding GroupN/A$7.63-2.7%N/AN/A$54.55M$29.87M0.00298MNPRMonopar Therapeutics3.9888 of 5 stars$15.18-6.4%$22.00+44.9%+432.0%$53.43MN/A-6.6010Gap Down Related Companies and Tools Related Companies KRON Alternatives IMRX Alternatives BRNS Alternatives SPRO Alternatives EVOK Alternatives THTX Alternatives ATNM Alternatives CALC Alternatives BGM Alternatives MNPR Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BCTX) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
